Pneumonia

Pneumonia Features

VIEW ALL
COVID-19 Tips for Reducing Needle Anxiety to Increase Vaccination Rates Among Children
By Jessica Nye, PhD
Effective Strategies for Vaccine Communication

Pneumonia News

VIEW ALL
STRIDE-10 Results Support Merck’s 21-Valent Pneumococcal Conjugate Vaccine
The phase 3 STRIDE-10 trial evaluated the safety and immunogenicity of V116 in pneumococcal vaccine-naive adults 50 years of age and older.
Inappropriate Diagnosis of Pneumonia Common in Hospitalized Adults

Inappropriate diagnosis common, especially in older patients and those with dementia, altered mental status on presentation

Short-Course VAP Antibiotic Treatment Does Not Result in Inferior Outcomes
A clinical trial evaluated outcomes of a short-duration antibiotic course vs usual care for treating ventilator-associated pneumonia (VAP).
Merck’s 21-Valent Pneumococcal Conjugate Vaccine Gets FDA’s Priority Review
The application is supported by data from several phase 3 studies in the V116 clinical development program.
Data Support Immunogenicity of 21-Valent Pneumococcal Conjugate Vaccine
The STRIDE-3 trial evaluated the safety and immunogenicity of V116 in pneumococcal vaccine-naïve adults 18 years of age and older.

  • Latest News Your top articles for Wednesday

  • Haymarket Medical NetworkTop Picks

  • Loading...

    Continuing Medical Education (CME/CE) Courses

    Show More